- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05363137
Effectiveness of Using a Chatbot to Promote Adherence to Home Physiotherapy
September 2, 2022 updated by: Jose María Blasco Igual, University of Valencia
Herramienta de Procesamiento de Lenguaje Natural en Dispositivo móvil Inteligente Para Fomentar la Adherencia a la rehabilitación Domiciliaria
A Chatbot oriented to virtually assist patients in a physiotherapy treatment has been designed and developed to interact with patients with musculoskeletal disorders in need for domiciliary rehabilitation.
The tool has been designed to promote adherence to rehabilitation, what in turn may have an impact on clinical outcome.
A randomized clinical trial involving patients undergoing total knee replacement has bee designed to determine the applicability of the proposal.
The participants will be assigned into exerimental group (intervention with the software tool) or control group (standard care).
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: José M Blasco, PhD
- Phone Number: 51313 +34 963 98 38 55
- Email: jose.maria.blasco@uv.es
Study Locations
-
-
-
Valencia, Spain, 46026
- Recruiting
- Hospital La Fe
-
Contact:
- Sergio Roig, phd, PT
- Email: sergio.roig@uv.es
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 75 years (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Individuals on the waiting list for total knee replacement surgery
- Undergoing primary total knee replacement surgery
- Who have a personal smartphone
- Who have an instant messaging application installed
- Familiar with the use of such application (more than 3 accesses per week),
Exclusion Criteria:
- Evident cognitive state that prevents to understand care provider instructions
- Vestibular or central nervous system affection (e.g. stroke)
- Cannot read or write
- Do not understand Spanish language
- Not able to consent to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Control
|
The physiotherpy treatment will be standard care
|
EXPERIMENTAL: Experimental
|
The physiotherpy treatment will be supervised via chatbot
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence
Time Frame: Change from baseline to 3 months after surgery date
|
Compliance with intervention measured as the percentage of sessions carried out with respect to the total planned
|
Change from baseline to 3 months after surgery date
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: Change from baseline to 3 months and one year after surgery date
|
Self-administered questionnaire consisting of 24 items divided into pain, stiffness and physical function will register self-reported status.
The score is given from 0 to 100
|
Change from baseline to 3 months and one year after surgery date
|
Knee Pain
Time Frame: Change from baseline to 3 months and one year after surgery date
|
Measured with a visual analogue scale of pain, being 0 no pain and 10 the worst possible pain
|
Change from baseline to 3 months and one year after surgery date
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety
Time Frame: Baseline (surgery day) to 12 months
|
Adverse events, defined as any unfavorable or unintended diagnosis, sign, symptom, or disease associated with the study
|
Baseline (surgery day) to 12 months
|
Feasibility_1
Time Frame: Time from initial day to last day of recruitment up to two years
|
Recruitment rate, obtained by dividing the number of participants divided by the number patients invited
|
Time from initial day to last day of recruitment up to two years
|
Feasibility_2
Time Frame: Time from initial day to 3 months after surgery date
|
Retention rate, obtained by dividing the number of participants assessed at three months by the total number of participants
|
Time from initial day to 3 months after surgery date
|
International Physical Activity Questionnaire (IPAQ-E)
Time Frame: Change from baseline to 3 months after surgery date
|
This questionnaire is used to measure the types of intensity of physical activity and sitting time as part of the participants' daily lives, i.e. the total physical activity in MET-min/week and time spent sitting
|
Change from baseline to 3 months after surgery date
|
System Usability
Time Frame: Change from baseline to 3 months after surgery date
|
System usability scale will be used for measuring the usability; this consists of a 10 item questionnaire with five response options from Strongly agree to Strongly disagree
|
Change from baseline to 3 months after surgery date
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2022
Primary Completion (ANTICIPATED)
June 1, 2023
Study Completion (ANTICIPATED)
June 1, 2024
Study Registration Dates
First Submitted
May 2, 2022
First Submitted That Met QC Criteria
May 2, 2022
First Posted (ACTUAL)
May 5, 2022
Study Record Updates
Last Update Posted (ACTUAL)
September 8, 2022
Last Update Submitted That Met QC Criteria
September 2, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NLP-PTAdherence
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Thammasat UniversityCompletedPrimary Knee OsteoarthritisThailand
-
Galderma R&DCompletedUnilateral Knee OsteoarthritisUnited Kingdom
-
National Yang Ming UniversityFar Eastern Memorial HospitalCompletedMedial Knee OsteoarthritisTaiwan
-
Hanlim Pharm. Co., Ltd.CompletedKnee OsteoarthritisKorea, Republic of
Clinical Trials on Chatbot Assistant
-
Seoul National University HospitalCompletedDental Contact During Direct LaryngoscopyKorea, Republic of
-
University of Maryland, College ParkCompletedCervical Cancer | Anal Cancer | Penile CancerUnited States
-
Yonsei UniversityCompletedBreast NeoplasmsKorea, Republic of
-
Weill Medical College of Cornell UniversityRecruitingGynecologic Cancer | Hereditary Cancer SyndromeUnited States
-
Sun Yat-sen UniversityRecruiting
-
Cheng-Hsin General HospitalRecruitingLower Urinary Tract Symptoms | Erectile Dysfunction | Benign Prostate EnlargementTaiwan
-
Abramson Cancer Center at Penn MedicineRecruitingHead and Neck Cancer | Lung Cancer | Gastrointestinal CancerUnited States
-
Convergent Engineering, Inc.National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaboratorsNot yet recruitingRespiratory Therapy
-
University of Social Sciences and Humanities, WarsawMinistry of Science and Higher Education, PolandCompletedDepression | AnxietyPoland
-
Adonis Hijaz, MDRecruiting